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Long term accuracy of fluorescence polarization
immunoassays for gentamidn, tobramydn, netilmidn
and vancomydn
Beda Joos, Roedi Lfithy and Jflrg Blaser
Division of Infectious Diseases, Department of Medicine,
University Hospital, CH-8091 Zurich, Switzerland
External quality control was performed during six years to determine the accuracy
over time of the Abbott TDx fluorescence polarization system for assaying anti-
biotics. Unknown spiked serum samples of gentamicin, tobramytin, netilmicin and
vancomycin were provided monthly by the British national external quality assess-
ment scheme. Comparison of the 209 assay results with the target concentrations
showed good correlations in all four assays. No significant deviations from linearity,
from slope 10, and from intercept 00 were detected by regression analysis. Relative
deviations were < 10% and < 15% for 78% and 90% of all specimens, respect-
ively. On an average the same calibration curves could be used over a period of 19
weeks . Fluorescence polarization immunoassays provided rapid and reliable results
over the entire study period.
Introduction
The aminoglycosides and vancomycin are the most frequently assayed antibiotics in
clinical practice (Wenk, Vozeh & Follath, 1984). Monitoring is mandatory due to their
low therapeutic index and poor predictability of serum concentrations. Thus reliable
determinations of serum levels are essential to optimize individual dosage regimens.
Fluorescence polarization immunoassays are widely used to analyse clinical specimens.
The principle of these competitive binding immunoassays (Jolley etaJ., 1981a) and of
the automated fluorescence polarization analyser (Popelka etal., 1981) as well as
performance in comparison with other assay methods (Jolley etal., 1981fc) have been
previously described.
An external quality control was performed over a six year period, to determine the
accuracy of the Abbott TDx fluorescence polarization system for assaying antibiotics,
supplement internal quality control procedures, study possible changes in the quality of
performance over time, and to recognize and minimize systematic errors.
Materials and methods
Specimens
Human serum samples, each spiked with one antibiotic, were obtained monthly from
the British national external quality assessment scheme (NEQAS), antibiotic assays
section (Department of Medical Microbiology, Southmead Hospital, Bristol, UK).
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Specimens were available for the following antibiotics and time periods: gentamicin
(number of samples, n = 62) and tobramycin (n = 61), November 1982 to October
1988; netilmicin (n = 38), since February 1985; vancomycin (n = 48), since February
1984. The total number of analyses of patient samples for all four antibiotics increased
from 5000 to 15,000 per year during the study period.
Assays
The unknown specimens were treated in exactly the same manner as routine samples.
No replicate analyses were performed. Results were reported immediately to the
Antibiotic Assay Quality Control Section, Southmead Hospital. Target values were not
known before receipt of the subsequent specimen distribution. Assays were done on an
Abbott TDx analyser using reagent kits obtained from Abbott, Switzerland. Assays
were calibrated using standard solutions, also supplied by Abbott, according to kit
protocols. Three control sera containing 1, 4, and 8 mg/1 of an aminoglycoside or 7, 35,
and 75 mg/1 of vancomycin were run periodically to validate the actual calibration
curve. Deviations of 10% from the intermediate and high, and of 15% from the low
concentration were permitted in this internal control. Reagents, calibrators, and
controls were stored in accordance with the manufacturers recommendations.
Statistical evaluation
The sets of data were evaluated by least squares linear regression, by standardized
principal component analysis (Feldmann etal., 1981), and by the distribution indepen-
dent regression procedure of Passing & Bablok (1983, 1984). Outliers were not
eliminated. Linearity was tested by using the cusum-test and the run-test (test for
randomness) after sorting projections of the data points along the regression line
(Passing & Bablok, 1983). The same two tests were used to assess whether the
deviations were randomly distributed over time.
Results
Regression analysis
Figures 1 to 4 show concentrations of the four antibiotics measured by fluorescence
polarization immunoassays plotted against the corresponding target values and the
estimated regression parameters by the method of Passing & Bablok (1983). No
significant deviations from slope = 1-0 and intercept = OK) and no significant devia-
tion from linear relationship were detected for each drug. Ninety-five percent confi-
dence intervals of slopes were from 0-978 to 1-061 for gentamicin, 0-940 to 1-000 for
tobramycin, 0-929 to 1-033 for netilmicin, 0-959 to 1-078 for vancomycin, and 0-995 to
1-024 for the joined data. For the intercepts the 95% confidence limits were within
-0-21 and 0-28 mg/1 for the aminoglycosides and from —1-08 to 1-38 mg/1 for vanco-
mycin.
All slopes and intercepts estimated by the standardized principal component analyses
(slopes from 0-979 to 1-024) and by linear least squares regressions (slopes 0-950 to
1-004) ranged within the 95% confidence limits obtained from the corresponding
Passing & Bablok regression. Coefficients of correlation were > 0-97 in each evalu-
ation.
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Figure 1. Gentamidri results plotted against tbe respective target values in 62 spiked serum samples during
a six year period. Correlation coefficient - O98; , y = 0200+ 1-OOOJT, , 95% confidence limits.
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Figure 2. Tobramydn results of 61 specimens obtained over a six year period. Correlation coeffident -
097; , y «. O067 + 0972* . . . . . 95% confidence limits.
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Figure 3. Netihnkin results of 38 specimens obtained over a four year period. Correlation coefficient
O982; , y = -(M)33 + (W78;r, 95% confidence limits.
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Fignre 4. Vancomydn results of 48 specimens obtained over a five year period Correlation coefficient
(W82; , y - -0-136+ 1-019JT, . . . . . 95V. confidence limits.
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Ftgntc 5. Accuracy of the fluorescence polarization tmmunoassays plotted as cumulative frequency of
positive or negative deviations given in percent of the target concentrations. , Gentamicin;
, tobramycin; —. — .—, netihnicin; . . . . . vancomyem.
Absolute deviations
Differences between individual assay results and the corresponding target values ranged
from —0-6 to + 2-4 mg/1 with gentamicin, — 3-9 to +1-2 mg/1 with tobramycin, —1-2 to
+ 1-1 mg/1 with netilmicin, and —8-3 to +6-8 mg/1 with vancomycin. For each of the
aminoglycosides 50% of the absolute deviations did not exceed 0-2 mg/1 and 90% of the
differences were 0-7 mg/1 or less, while 50% and 90% of the vancomycin results
deviated at most by 1-2 and 41 mg/1, respectively.
Relative deviations
Positive or negative deviations of less than 10% were observed in 79%, 85%, 82%, and
63% of all gentamicin, tobramycin, netilmicin, and vancomycin results, respectively
(Figure 5). Deviations from target concentrations were less than 15% in 90%, 90%,
97%, and 81% of the respective results. In 206 of the 209 samples (98-6%) relative
differences ranged from - 1 5 % to +21%. Deviations of +32%, +36%, and - 4 5 %
were obtained in the other three samples. Retrospective reanalyses of these three
samples were close to the target values (—6% to +11% deviations), despite two to
three years storage at — 20°C.
Time series
Deviations were arranged consecutively in each data set and subjected to cusum- and
run-tests. The runs up and down of increasing or decreasing relative differences were
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randomly distributed over time for each antibiotic. Testing for the sequence of
observations above and below the target values showed no systematic deviation from
randomness for tobramycin and netilmicin. A lack of randomness was detected by this
evaluation for gcntamicin and vancomycin, because the gentamicin results contained 12
consecutive values above the target and vancomycin had series of eight values on either
side.
Standard curve
The stability of the calibration curves was analysed over the last two years of the study
period. Three spiked sera were analyzed per drug and week as internal controls. On an
average, recalibrations were needed every 17, 21, 26, and 13 weeks for gentamicin,
tobramycin, netilmicin, and vancomycin, respectively.
Discussion
External quality control is the most stringent way of testing the accuracy of an assay
procedure. Blind analysis and immediate reporting of the results truly reflects the
everyday situation in a clinical laboratory. The present study covered all potential
laboratory errors which might possibly occur during handling and analysing of
specimens and reporting of the results.
Comparison of fluorescence polarization immunoassay results with the corres-
ponding target concentrations snowed good agreement for gentamicin, tobramycin,
netilmicin, and vancomycin. Linear regression analyses performed,by conventional
least squares regression and by standardized principal component analysis revealed
almost identical slopes and intercepts. However, these regression techniques may not be
optimal to analyse the experimental data. In contrast to the standard procedures, the
method suggested by Passing & Bablok (1983) does not rely on the assumption of a
normal distribution of either the measured values or the errors, and the result is not
markedly influenced by extreme outliers. Nevertheless, the slopes and intercepts
estimated by least squares regression and by standardized principal component analysis
were within the confidence limits of the regression parameters as defined by Passing &
Bablok (1983).
External quality controls on a voluntary basis are no substitute for frequent internal
controls, required for immediate detection of methodological problems. According to
the recommendations of the manufacturer deviations of 10% to 15% were tolerated for
the internal controls, which appears adequate for therapeutic drug monitoring. The
deviations from target values of the blind external quality assessment were within the
error limits of the open internal controls for the great majority of specimens. Only in
two instances the assay result was wrong to the extent that a different dosage
recommendation would have been suggested. Errors attributable to preparation of the
spiked specimens or to alterations during shipment never became obvious in this
evaluation. Retrospective reanalyses of extreme outliers confirmed the target concen-
trations.
Calibration curves were usually valid for several months. Major reasons for recalib-
ration were optical or mechanical realignment of the apparatus during routine main-
tenance or changes in reagent lots. In order to minimize the latter problem it is our
policy to keep sufficient stock of reagents of identical lots. The need for more frequent
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recalibrations with vancomycin than with the aminoglycosides may be attribu-
table to the inferior stability of this compound at room temperature. For the three
aminoglycosides the length of calibration-free intervals was increased with increased
numbers of specimens analyzed. Thus performance appears to be improved when
reagent packs are used up within a short time after opening.
In conclusion, the Abbott TDx fluorescence polarization immunoassays for genta-
micin, tobramycin, netilmicin and vancomycin provided reliable results in this long
term external quality assessment.
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